Literature DB >> 32541201

High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases.

Elizabeth T Jensen1, Seema S Aceves2, Peter A Bonis3, Kimberly Bray4, Wendy Book5, Mirna Chehade6, Margaret H Collins7, Evan S Dellon8, Gary W Falk9, Nirmala Gonsalves10, Sandeep K Gupta11, Ikuo Hirano10, David A Katzka12, Shay Kyle13, Denise Mack5, Ellyn Kodroff13, John Leung14, Vincent A Mukkada15, Melissa Scott16, Ally Paliana13, Kathleen Sable5, Jonathan M Spergel17, Mary Jo Strobel5, Jeffrey Krischer4, Marc E Rothenberg18, Pablo Abonia18.   

Abstract

OBJECTIVES: Clinical features of eosinophilic esophagitis (EoE) have been well-described in the literature, however, characterization of features experienced by patients with other eosinophilic gastrointestinal diseases (EGIDs) is lacking. Using data collected from a patient contact registry, we sought to characterize and contrast patient-reported gastrointestinal and extragastrointestinal symptoms and comorbidities in non-EoE EGIDs, including eosinophilic gastritis, gastroenteritis and colitis, relative to EoE.
METHODS: We conducted a cross-sectional study of contact registry data collected from 2015 to 2018. Statistical comparisons were made using chi-square (categorical measures) and the Mann-Whitney U test (continuous measures). Multivariable analyses were used to evaluate associations between treatment and feelings of isolation.
RESULTS: Of the 715 reporting an EGID diagnosis (n = 525 EoE; n = 190 non-EoE EGID), a higher proportion of those with a non-EoE EGID reported more frequent specific and nonspecific gastrointestinal symptoms, including nausea, abdominal pain, diarrhea, constipation, and bloating (P < 0.01 for all). Participants with a non-EoE EGID were more likely to report higher frequency of fatigue, isolation, and deep muscle or joint pain (P < 0.01 for all). Specific food elimination and elemental formula treatments were associated with increased odds of more frequent (at least weekly) feelings of isolation for participants with EoE (adjusted odds rtaio [aOR]: 2.4; 95% confidence interval [CI]: 1.5--4.1 for specific food elimination and adjusted OR: 1.9; 95% CI: 1.2--3.3 for elemental formula).
CONCLUSIONS: Significant differences exist in the symptoms and comorbidities experienced between those with EoE versus non-EoE EGIDs. Additional investigation is needed to elucidate the factors that may contribute to the high disease burden of these poorly understood conditions.

Entities:  

Mesh:

Year:  2020        PMID: 32541201      PMCID: PMC7574400          DOI: 10.1097/MPG.0000000000002817

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   3.288


  24 in total

1.  The Rare Diseases Clinical Research Network Contact Registry update: features and functionality.

Authors:  Rachel L Richesson; Rebecca Sutphen; Denise Shereff; Jeffrey P Krischer
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

Review 2.  Cutaneous findings of connective tissue disease.

Authors:  T F Zachian; A F Santoro
Journal:  Compr Ther       Date:  1998-04

3.  Development of a questionnaire to measure quality of life in adolescents with food allergy: the FAQL-teen.

Authors:  Elena S Resnick; Mariah M Pieretti; Jennifer Maloney; Sally Noone; Anne Muñoz-Furlong; Scott H Sicherer
Journal:  Ann Allergy Asthma Immunol       Date:  2010-11       Impact factor: 6.347

4.  Epidemiology of shoulder dislocations presenting to emergency departments in the United States.

Authors:  Michael A Zacchilli; Brett D Owens
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

5.  Variations in quality of life among caregivers of food allergic children.

Authors:  Elizabeth E Springston; Bridget Smith; Joshua Shulruff; Jacqueline Pongracic; Jane Holl; Ruchi S Gupta
Journal:  Ann Allergy Asthma Immunol       Date:  2010-10       Impact factor: 6.347

6.  Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017.

Authors:  Emad Mansoor; Mohannad Abou Saleh; Gregory S Cooper
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-08       Impact factor: 11.382

Review 7.  Eosinophilic gastrointestinal disorders associated with autoimmune connective tissue disease.

Authors:  Marie Lecouffe-Desprets; Matthieu Groh; Bruno Bour; Claire Le Jeunne; Xavier Puéchal
Journal:  Joint Bone Spine       Date:  2015-12-19       Impact factor: 4.929

8.  Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care.

Authors:  Girish Hiremath; Ellyn Kodroff; Mary J Strobel; Melissa Scott; Wendy Book; Cathy Reidy; Shay Kyle; Denise Mack; Kathleen Sable; Pablo Abonia; Jonathan Spergel; Sandeep K Gupta; T Glenn Furuta; Marc E Rothenberg; Evan S Dellon
Journal:  Clin Res Hepatol Gastroenterol       Date:  2018-03-31       Impact factor: 2.947

9.  Health-related quality of life among adults with diverse rare disorders.

Authors:  Kathleen R Bogart; Veronica L Irvin
Journal:  Orphanet J Rare Dis       Date:  2017-12-07       Impact factor: 4.123

10.  Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Authors:  Katherine Cheng; Sandeep K Gupta; Susanna Kantor; Jonathan T Kuhl; Seema S Aceves; Peter A Bonis; Kelley E Capocelli; Christina Carpenter; Mirna Chehade; Margaret H Collins; Evan S Dellon; Gary W Falk; Rashmi Gopal-Srivastava; Nirmala Gonsalves; Ikuo Hirano; Eileen C King; John Leung; Jeffrey P Krischer; Vincent A Mukkada; Alain Schoepfer; Jonathan M Spergel; Alex Straumann; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  Transl Sci Rare Dis       Date:  2017-12-18
View more
  6 in total

1.  International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Authors:  Evan S Dellon; Nirmala Gonsalves; J Pablo Abonia; Jeffrey A Alexander; Nicoleta C Arva; Dan Atkins; Stephen E Attwood; Marcus K H Auth; Dominique D Bailey; Luc Biederman; Carine Blanchard; Peter A Bonis; Paroma Bose; Albert J Bredenoord; Joy W Chang; Mirna Chehade; Margaret H Collins; Carlo Di Lorenzo; Jorge Amil Dias; Ranjan Dohil; Christophe Dupont; Gary W Falk; Cristina T Ferreira; Adam T Fox; Robert M Genta; Thomas Greuter; Sandeep K Gupta; Ikuo Hirano; Girish S Hiremath; Jennifer L Horsley-Silva; Shunji Ishihara; Norihisa Ishimura; Elizabeth T Jensen; Carolina Gutiérrez-Junquera; David A Katzka; Paneez Khoury; Yoshikazu Kinoshita; Kara L Kliewer; Sibylle Koletzko; John Leung; Chris A Liacouras; Alfredo J Lucendo; Lisa J Martin; Emily C McGowan; Calies Menard-Katcher; David C Metz; Talya L Miller; Fouad J Moawad; Amanda B Muir; Vincent A Mukkada; Simon Murch; Quan M Nhu; Ichiro Nomura; Samuel Nurko; Yoshikazu Ohtsuka; Salvatore Oliva; Rok Orel; Alexandra Papadopoulou; Dhyanesh A Patel; Robert D Pesek; Kathryn A Peterson; Hamish Philpott; Philip E Putnam; Joel E Richter; Rachel Rosen; Melanie A Ruffner; Ekaterina Safroneeva; Philipp Schreiner; Alain Schoepfer; Shauna R Schroeder; Neil Shah; Rhonda F Souza; Stuart J Spechler; Jonathan M Spergel; Alex Straumann; Nicholas J Talley; Nikhil Thapar; Yvan Vandenplas; Rajitha D Venkatesh; Mario C Vieira; Ulrike von Arnim; Marjorie M Walker; Joshua B Wechsler; Barry K Wershil; Benjamin L Wright; Yoshiyuki Yamada; Guang-Yu Yang; Noam Zevit; Marc E Rothenberg; Glenn T Furuta; Seema S Aceves
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-16       Impact factor: 13.576

2.  Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.

Authors:  Tetsuo Shoda; Margaret H Collins; Mark Rochman; Ting Wen; Julie M Caldwell; Lydia E Mack; Garrett A Osswald; John A Besse; Yael Haberman; Seema S Aceves; Nicoleta C Arva; Kelley E Capocelli; Mirna Chehade; Carla M Davis; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Paneez Khoury; Amy Klion; Calies Menard-Katcher; John Leung; Vincent A Mukkada; Philip E Putnam; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Glenn T Furuta; Lee A Denson; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2022-01-25       Impact factor: 33.883

3.  Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.

Authors:  Marc E Rothenberg; Shawna K B Hottinger; Nirmala Gonsalves; Glenn T Furuta; Margaret H Collins; Nicholas J Talley; Kathryn Peterson; Calies Menard-Katcher; Macie Smith; Ikuo Hirano; Robert M Genta; Mirna Chehade; Sandeep K Gupta; Jonathan M Spergel; Seema S Aceves; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2021-12-22       Impact factor: 10.793

4.  "My Body Hates Me": A Qualitative Analysis of the Experience of Functional Nausea in Adolescent Girls and Their Mothers.

Authors:  Michelle A T Cole; Dima Qu'd; Marcus G Wild; Alexandra C Russell; Aimee R Caillet; Amanda L Stone
Journal:  Children (Basel)       Date:  2020-07-26

5.  Improving Care in Eosinophil-Associated Diseases: A Charter.

Authors:  David J Jackson; Praveen Akuthota; Rebeca Andradas; Albert J Bredenoord; Amanda Cordell; Sarah Gray; Joyce Kullman; Sameer K Mathur; Ian Pavord; Florence Roufosse; Christian Rubio; Irena Clisson Rusek; Dagmar Simon; Mary Jo Strobel; Tonya Winders
Journal:  Adv Ther       Date:  2022-04-30       Impact factor: 4.070

6.  Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.

Authors:  Line Tegtmeier Frandsen; Signe Westmark; Dorte Melgaard; Anne Lund Krarup
Journal:  United European Gastroenterol J       Date:  2021-09-03       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.